CompletedNCT05993429

Diagnostic Efficacy of EUS-FNA/B Versus ERCP With or Without POCS-TB in Patients With Suspected Hilar Cholangiocarcinoma

Studying Perihilar cholangiocarcinoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Qilu Hospital of Shandong University
Principal Investigator
Ning Zhong, MD
Qilu Hospital of Shandong University
Intervention
The sampling method selected in patients with suspected hilar cholangiocarcinoma(diagnostic_test)
Enrollment
200 enrolled
Eligibility
All sexes
Timeline
2023 – 2025

Study locations (1)

Collaborators

First Affiliated Hospital, Sun Yat-Sen University · First Affiliated Hospital of Guangxi Medical University · LanZhou University · Beijing Friendship Hospital · Binzhou Medical University · Shandong Provincial Hospital · Shandong Province Third hospital · Sir Run Run Shaw Hospital · The Third Xiangya Hospital of Central South University · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05993429 on ClinicalTrials.gov

Other trials for Perihilar cholangiocarcinoma

Additional recruiting or active studies for the same condition.

See all trials for Perihilar cholangiocarcinoma →

← Back to all trials